Stevanato Group Expands Drug Delivery Manufacturing in Germany to Boost Global Capacity
MT Newswires Live
Oct 21, 2025
Stevanato Group (STVN) said Tuesday it has expanded its drug delivery system manufacturing capacity by adding a state-of-the-art production space for drug delivery devices at its facility in Bad Oeynhausen, northern Germany.
The company said the upgrade adds more than 2,500 square meters of advanced production space, including a new ISO 8 cleanroom for injection molding and automated assembly operations.
The multi-million-euro investment will enhance its capacity to serve pharma and biotech clients across Europe and beyond, the company added, adding that the facility will also support production of key devices such as the Aidaptus autoinjector and Alina pen injector.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.